Document Type : Case reports

Author

Pediatric Endocrinology Unit, Bilkent City Hospital, 06800, Ankara, Turkey

Abstract

Introduction: 17 alpha-hydroxylase deficiency (17-OHD) is an infrequent autosomal recessive disorder in adrenal and gonadal steroidogenesis due to the CYP17A1 defect. Affected girls are characterized by delayed puberty, absence of secondary sex characteris- tics at puberty, and primary amenorrhea. Affected boys show female or ambiguous genitalia. Hormone imbalances result in varying degrees of hypertension and hypokalemia. The increase in corticosterone levels prevents the development of typical adrenal insuf- ficiency symptoms. Glucocorticoid and sex steroid supplementation is the preferred treatment.
Case Presentation: We reported two phenotypically female siblings, aged 14 and 25 years, with the 17-OHD from Ankara, the capital city of Turkey. The younger child had a 46,XX karyotype and the older had a 46,XY chromosome pattern. Another feature of the second patient (aged 25 years), was the presence of a large myelolipoma in her right adrenal gland.
Conclusions: 17 alpha-hydroxylase patients are usually diagnosed late, and unlike patients with other forms of congenital adrenal hyperplasia, hypertension is the major finding, and 10% - 15% of patients have normal blood pressure at diagnosis. The delay in diagnosis causes hypertension and renovascular changes, psychological problems, osteoporosis, and irreversible damage to breast tissue.

Keywords

  1. Kim SM, Rhee JH. A case of 17 alpha-hydroxylase deficiency. Clin Exp Reprod Med. 2015;42(2):72-6. doi: 10.5653/cerm.2015.42.2.72. [PubMed: 26161337]. [PubMed Central: PMC4496435].
  2. Kim YM, Kang M, Choi JH, Lee BH, Kim GH, Ohn JH, et al. A review of the literature on common CYP17A1 mutations in adults with 17-hydroxylase/17,20-lyase deficiency, a case series of such mutations among Koreans and functional characteristics of a novel mutation. Metabolism. 2014;63(1):42-9. doi: 10.1016/j.metabol.2013.08.015. [PubMed: 24140098].
  3. Costenaro F, Rodrigues TC, Kater CE, Auchus RJ, Papari-Zareei M, Czepielewski MA. Combined 17alpha-hydroxylase/17,20-lyase deficiency due to p.R96W mutation in the CYP17 gene in a Brazilian patient. Arq Bras Endocrinol Metabol. 2010;54(8):744-8. doi: 10.1590/s0004-27302010000800014. [PubMed: 21340163].
  4. Auchus RJ. Steroid 17-hydroxylase and 17,20-lyase deficiencies, genetic and pharmacologic. J Steroid Biochem Mol Biol. 2017;165(Pt A):71-8. doi: 10.1016/j.jsbmb.2016.02.002. [PubMed: 26862015]. [PubMed Central: PMC4976049].
  5. Athanasoulia AP, Auer M, Riepe FG, Stalla GK. Rare missense P450c17 (CYP17A1) mutation in exon 1 as a cause of 46,XY disorder of sexual development: implications of breast tissue 'unresponsiveness' despite adequate estradiol substitution. Sex Dev. 2013;7(4):212-5. doi: 10.1159/000348301. [PubMed: 23466679].
  6. Deeb A, Al Suwaidi H, Attia S, Al Ameri A. 17-hydroxylase/17,20-lyase deficiency due to a R96Q mutation causing hypertension and poor breast development. Endocrinol Diabetes Metab Case Rep. 2015;2015:150069. doi: 10.1530/EDM-15-0069. [PubMed: 26543560]. [PubMed Central: PMC4633651].
  7. Brooke AM, Taylor NF, Shepherd JH, Gore ME, Ahmad T, Lin L, et al. A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase/17,20-lyase deficiency. J Clin Endocrinol Metab. 2006;91(6):2428-31. doi: 10.1210/jc.2005-2653. [PubMed: 16569739].
  8. Beas F, Vargas L, Spada RP, Merchak N. Pseudoprecocious puberty in infants caused by a dermal ointment containing estrogens. The Journal of Pediatrics. 1969;75(1):127-30. doi: 10.1016/s0022-3476(69)80113-7.
  9. German-Mena E, Zibari GB, Levine SN. Adrenal myelolipomas in patients with congenital adrenal hyperplasia: review of the literature and a case report. Endocr Pract. 2011;17(3):441-7. doi: 10.4158/EP10340.RA. [PubMed: 21324823].